You are here: Industry Insights > HIV vaccine

News List

Oxford researchers launch HIV vaccine trial pharmatimes
July 07, 2021
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants.
HIV vaccine nears clinical trial following new findings worldpharmanews
July 30, 2019
A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version.
J&J announces PPP for Investigational Prophylactic HIV Vaccine biospectrumasia
July 16, 2019
Janssen’s mosaic vaccine is designed as a global vaccine with the goal of preventing infections from the wide range of viral strains responsible for the HIV pandemic
J&J announce promising Phase 1/2a results for HIV vaccine pharmafile
October 25, 2018
The world may be one step closer to discovering a preventative vaccine for HIV following American multinational Johnson & Johnson's announcement of promising...
HIV vaccine to come?! Play without scruple from now on? No!!! en-cphi.cn
August 18, 2017
The news of an HIV vaccine appROACH in development titled J & J announced 100% production of antibody has flooded the websites.
HIV vaccine shows ‘encouraging’ early results pharmaphorum
July 25, 2017
Janssen has unveiled what it calls ‘encouraging’ early results of its vaccine to prevent infection by HIV.
Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study cphi-online
May 31, 2017
Amongst highest levels of immune responses ever demonstrated in an HIV vaccine human study.
Inovio’s NIH-backed HIV vaccine shows near 100% immune response rate in early test fiercepharma
May 27, 2017
Inovio is one step closer in the race to create an effective HIV vaccine. Data from an early-stage clinical study showed that its Pennvax-GP could elicit an immune response in nearly all participants.
With $7M NIH grant, Inovio set to test HIV vaccine with a checkpoint inhibitor fiercepharma
April 06, 2017
After successfully shepherding a Zika vaccine candidate into the clinic before any other developer, Inovio Pharmaceuticals is amping up its efforts in HIV.
US researchers develop new approach to improve HIV vaccine effectiveness pharmaceutical-technology
April 06, 2017
Researchers from the University of Nebraska-Lincoln in the US have developed a new approach that could improve the safety and effectiveness of a potential vaccine for the HIV virus.